Figure 1‑1: Neurological Device Market Share Ranking by Segment, Global, 2022 (1 of 2) |
Figure 1‑2: Neurological Device Market Share Ranking by Segment, Global, 2022 (2 of 2) |
Figure 1‑3: Companies Researched in This Report (1 of 2) |
Figure 1‑4: Companies Researched in This Report (2 of 2) |
Figure 1‑5: Factors Impacting the Neurological Device Market by Segment, Global (1 of 2) |
Figure 1‑6: Factors Impacting the Neurological Device Market by Segment, Global (2 of 2) |
Figure 1‑7: Recent Events in the Neurological Device Market, Global, 2019 – 2023 (1 of 2) |
Figure 1‑8: Recent Events in the Neurological Device Market, Global, 2019 – 2023 (2 of 2) |
Figure 1‑9: Global Neurological Device Procedures Covered |
Figure 1‑10: Global Neurological Device Markets Covered |
Figure 1‑11: Neurological Device Regions Covered, Global (1 of 2) |
Figure 1‑12: Neurological Device Regions Covered, Global (2 of 2) |
Figure 1‑13: Version History |
Figure 2‑1: Neurological Device Market by Segment, Worst Case Scenario, Global, 2019 – 2029 (US$M) (1 of 2) |
Figure 2‑2: Neurological Device Market by Segment, Worst Case Scenario, Global, 2019 – 2029 (US$M) (2 of 2) |
Figure 2‑3: Neurological Device Market by Segment, Base Case Scenario, Global, 2019 – 2029 (US$M) (1 of 2) |
Figure 2‑4: Neurological Device Market by Segment, Base Case Scenario, Global, 2019 – 2029 (US$M) (2 of 2) |
Figure 2‑5: Neurological Device Market by Segment, Best Case Scenario, Global, 2019 – 2029 (US$M) (1 of 2) |
Figure 2‑6: Neurological Device Market by Segment, Best Case Scenario, Global, 2019 – 2029 (US$M) (2 of 2) |
Figure 3‑1: Neurology Disease Overview |
Figure 4‑1: Shunt Types |
Figure 4‑2: Cerebrospinal Fluid Management by Company |
Figure 4‑3: Detachable Coils by Company |
Figure 4‑4: Liquid Embolics by Company |
Figure 4‑5: Neurovascular Guidewires by Company |
Figure 4‑6: Neurovascular Catheters by Company |
Figure 4‑7: Neurovascular Stent by Company |
Figure 4‑8: Aneurysm Clip Devices by Company |
Figure 4‑9: Neurovascular Thrombus Management Devices by Company |
Figure 4‑10: Neuromodulation Devices by Company |
Figure 4‑11: Intrathecal Pumps Devices by Company |
Figure 4‑12: Stereotactic Devices by Company |
Figure 4‑13: Class 2 Device Recall Natus EDS3 CSF External Drainage System |
Figure 4‑14: Class 2 Device Recall Medtronic PS Medical CSFFlow Control Valves |
Figure 4‑15: Class 2 Device Recall MicroVention Terumo Microplex 10, Helical 10 Soft |
Figure 4‑16: Class 2 Device Recall MicroVention Terumo HydroFrame 10 and 18 |
Figure 4‑17: Class 2 Device Recall MicroVention Terumo Microplex 10, Compass 10 |
Figure 4‑18: Class 2 Device Recall MicroVention Terumo HydroSoft 10, HydroSoft 3D |
Figure 4‑19: Class 2 Device Recall GALAXY G3 Mini Microcoil Delivery System |
Figure 4‑20: Class 2 Device Recall C315HIS Delivery Catheter |
Figure 4‑21: Class 2 Device Recall MIVI Super 90 Guide Catheters |
Figure 4‑22:Class 2 Device Recall MAMBA Flex 135 Microcatheter |
Figure 4‑23: Class 2 Device Recall Intracranial Neurovascular Stent |
Figure 4‑24: Class 2 Device Recall Medtronic Wireless Recharger |
Figure 4‑25: Class 2 Device Recall Model B352000 Percept PC BrainSense Implantable Neurostimulator |
Figure 4‑26: Class 2 Device Recall A610 |
Figure 4‑27: Class 2 Device Recall Percept PC Implantable Neurostimulator (INS) |
Figure 4‑28: Class 2 Device Recall Stealth Autoguide Tracker, Model: 28248 |
Figure 4‑29:Class 2 Device Recall Medtronic |
Figure 4‑30: Class 2 Device Recall Polaris Spectra Camera for StealthStation S7 System |
Figure 4‑31:Class 2 Device Recall Leksell Vantage Stereotactic System |
Figure 4‑32: Class 2 Device Recall Leksell Vantage Stereotactic System |
Figure 4‑33:Class 2 Device Recall ROSA Brain 3.0 Application Brain and ROSA One 3.1 |
Figure 4‑34: Class 2 Device Recall Prometra Programmable Pump System |
Figure 4‑35: Class 2 Device Recall Medtronic Synchromed II Implantable Drug Infusion Pump |
Figure 4‑36: Class 2 Device Recall AXS Vecta 71 , Vecta 74 Aspiration Catheter |
Figure 4‑37: Class 1 Device Recall MINDFRAME CAPTURE(TM) LP Revascularization Device |
Figure 4‑38: Class 2 Device Recall Trevo XP ProVue System |
Figure 4‑39: The Effect of Lumbar CSF Drainage on the Neurologic Outcome Improvement in OHCA Underwent TTM |
Figure 4‑40: Operative Procedures vs. Endovascular Neurosurgery for Untreated Pseudotumor Trial (OPEN-UP) |
Figure 4‑41: Stenting Versus Neurosurgical Treatment of Idiopathic Intracranial Hypertension. (HYDROPTIC) |
Figure 4‑42: SMART - A Prospective, Multicenter Study Assessing the Embolization of Neurovascular Lesions Using the Penumbra Smart Coil |
Figure 4‑43: Prospective, Randomized, Controlled, Open Label, All China, Multi-Center, Registration Trial of the MICROPORT NEUROTECH Coil Embolization System for the Traetment of Intracranial Aneurysms |
Figure 4‑44: Transcatheter Leak Closure with Detachable Coils Following Incomplete Left Atrial Appendage Closure Procedures (TREASURE) |
Figure 4‑45: Middle Meningeal Artery Embolization with Liquid Embolic Agent for Treatment of Chronic Subdural Hematoma |
Figure 4‑46: Treatment of Cerebral Arteriovenous Malformations with SQUID Liquid Embolic Agent - The CHOICE Study A Non-interventional, Prospective, Single-arm, International, Multicenter Study |
Figure 4‑47: Squid Liquid Embolic Agent for the Embolization of Abdominopelvic Arterial Bleeding Syndrome (SQUIDperi Study) (SQUIDperi) |
Figure 4‑48: Non-adhesive Liquid Embolic System in the Embolization of Cerebral Arteriovenous Malformations |
Figure 4‑49: SMART - A Prospective, Multicenter Study Assessing the Embolization of Neurovascular Lesions Using the Penumbra Smart Coil |
Figure 4‑50: Anti-Epilepsy Medication Valproate Administered Via ICV Route and Catheters and Pumps for CSF Infusion |
Figure 4‑51: Inflammatory and Infectious Diseases of the Nervous System |
Figure 4‑52: Safety and Utility Profile of the Asahi Chikai Black 18 neurovascular guidewire in Large Vessel Occlusive Stroke: SURE 18 Registry |
Figure 4‑53: Evaluation of Safety and Performance of the Neuroform AtlasTM Stent System for Intracranial Aneurysm Treatment - Post Market Clinical Follow-up |
Figure 4‑54: Safety and Effectiveness of the Treatment of Wide Neck, Intracranial, Saccular Aneurysms with the Next Generation Neuroform Stent System |
Figure 4‑55: MicroNet-covered Stent System for Stroke Prevention in All Comer Carotid Revascularization (PARADIGM-EXT) |
Figure 4‑56: The Motor Network in Essential Tremor: Mechanisms of Therapy |
Figure 4‑57: Wearable Neuromodulation DeVice for the TrEatment of Alzheimer's Disease (WAVE-AD) |
Figure 4‑58: A Pilot Clinical Trial of a New Neuromodulation Device for Acute Attacks of Migraine in Children and Adolescents Visiting the Emergency Department |
Figure 4‑59: Phase I Study of Stereotactic Radiosurgery Dose Escalation for Brain Metastases |
Figure 4‑60: Cyberknife Radiosurgery for Patients with Brain Metastases Diagnosed With Either SPACE or MPRAGE Sequence - A Prospective Randomized Evaluation of Response and Toxicity |
Figure 4‑61: Phase I TITE-CREM Dose Escalation Study of Fractionated Stereotactic Radiation Therapy (FSRT) in Unresected Brain Metastases |
Figure 4‑62: A Safety and Efficacy Study of NicaPlant® in Aneurysmal Subarachnoid Haemorrhage Patients Undergoing Aneurysm Clipping |
Figure 4‑63: Regional Strategy for Transfer for Mechanical Thrombectomy (START) |
Figure 4‑64: Evaluation of Mechanical Thrombectomy in Acute Ischemic Stroke Related to a Distal Arterial Occlusion (DISCOUNT) |
Figure 5‑1: Neurological Device Market by Segment, Global, 2019 – 2029 (US$M) (1 of 2) |
Figure 5‑2: Neurological Device Market by Segment, Global, 2019 – 2029 (US$M) (2 of 2) |
Figure 5‑3: Neurological Device Market by Region, Global, 2019 – 2029 (US$M) |
Figure 5‑4: Leading Competitors, Neurological Device Market by Segment, Global, 2022 (1 of 2) |
Figure 5‑5: Leading Competitors, Neurological Device Market by Segment, Global, 2022 (2 of 2) |
Figure 5‑6: SWOT Analysis, Abbott |
Figure 5‑7: SWOT Analysis, B. Braun |
Figure 5‑8 SWOT Analysis, Boston Scientific |
Figure 5‑9: SWOT Analysis, Integra LifeSciences |
Figure 5‑10: SWOT Analysis, LivaNova |
Figure 5‑11: SWOT Analysis, Medtronic |
Figure 5‑12: SWOT Analysis, MicroVention |
Figure 5‑13: SWOT Analysis, Mizuho |
Figure 5‑14: SWOT Analysis, Stryker |
Figure 6‑1: Cerebrospinal Fluid Management Markets Covered |
Figure 6‑2: Cerebrospinal Fluid Management Regions Covered, Global (1 of 2) |
Figure 6‑3: Cerebrospinal Fluid Management Regions Covered, Global (2 of 2) |
Figure 6‑4: Cerebrospinal Fluid Shunting Procedures by Region, Global, 2019 – 2029 |
Figure 6‑5: Cerebrospinal Fluid Shunting Procedures by Country, North America, 2019 – 2029 |
Figure 6‑6: Cerebrospinal Fluid Shunting Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
Figure 6‑7: Cerebrospinal Fluid Shunting Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
Figure 6‑8: Cerebrospinal Fluid Shunting Procedures by Country, Western Europe, 2019 – 2029 |
Figure 6‑9: Cerebrospinal Fluid Shunting Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
Figure 6‑10: Cerebrospinal Fluid Shunting Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
Figure 6‑11: Cerebrospinal Fluid Shunting Procedures by Country, Middle East, 2019 – 2029 |
Figure 6‑12: Cerebrospinal Fluid Shunting Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
Figure 6‑13: Cerebrospinal Fluid Shunting Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
Figure 6‑14: Cerebrospinal Fluid Shunting Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
Figure 6‑15: Cerebrospinal Fluid Shunting Procedures by Country, Africa, 2019 – 2029 |
Figure 6‑16: Cerebrospinal Fluid Management Market by Segment, Global, 2019 – 2029 (US$M) |
Figure 6‑17: Cerebrospinal Fluid Management Market by Region, Global, 2019 – 2029 (US$M) |
Figure 6‑18: Cerebrospinal Fluid Management Market, Global, 2019 – 2029 |
Figure 6‑19: Units Sold by Region, Cerebrospinal Fluid Management Market, Global, 2019 – 2029 |
Figure 6‑20: Average Selling Price by Region, Cerebrospinal Fluid Management Market, Global, 2019 – 2029 (US$) |
Figure 6‑21: Market Value by Region, Cerebrospinal Fluid Management Market, Global, 2019 – 2029 (US$M) |
Figure 6‑22: Cerebrospinal Fluid Shunt Market, Global, 2019 – 2029 |
Figure 6‑23: Units Sold by Region, Cerebrospinal Fluid Shunt Market, Global, 2019 – 2029 |
Figure 6‑24: Average Selling Price by Region, Cerebrospinal Fluid Shunt Market, Global, 2019 – 2029 (US$) |
Figure 6‑25: Market Value by Region, Cerebrospinal Fluid Shunt Market, Global, 2019 – 2029 (US$M) |
Figure 6‑26: Cerebrospinal Fluid Drainage System Market, Global, 2019 – 2029 |
Figure 6‑27: Units Sold by Region, Cerebrospinal Fluid Drainage System Market, Global, 2019 – 2029 |
Figure 6‑28: Average Selling Price by Region, Cerebrospinal Fluid Drainage System Market, Global, 2019 – 2029 (US$) |
Figure 6‑29: Market Value by Region, Cerebrospinal Fluid Drainage System Market, Global, 2019 – 2029 (US$M) |
Figure 6‑30: Leading Competitors, Cerebrospinal Fluid Management Market, Global, 2022 |
Figure 7‑1: Detachable Coil Markets Covered |
Figure 7‑2: Detachable Coil Regions Covered, Global (1 of 2) |
Figure 7‑3: Detachable Coil Regions Covered, Global (2 of 2) |
Figure 7‑4: Total Detachable Coil Procedures, Global, 2019 – 2029 |
Figure 7‑5: Detachable Coil Procedures by Region, Global, 2019 – 2029 |
Figure 7‑6: Detachable Coil Procedures by Country, North America, 2019 – 2029 |
Figure 7‑7: Detachable Coil Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
Figure 7‑8: Detachable Coil Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
Figure 7‑9: Detachable Coil Procedures by Country, Western Europe, 2019 – 2029 |
Figure 7‑10: Detachable Coil Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
Figure 7‑11: Detachable Coil Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
Figure 7‑12: Detachable Coil Procedures by Country, Middle East, 2019 – 2029 |
Figure 7‑13: Detachable Coil Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
Figure 7‑14: Detachable Coil Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
Figure 7‑15: Detachable Coil Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
Figure 7‑16: Detachable Coil Procedures by Country, Africa, 2019 – 2029 |
Figure 7‑17: Detachable Coil Market by Segment, Global, 2019 – 2029 (US$M) |
Figure 7‑18: Detachable Coil Market by Region, Global, 2019 – 2029 (US$M) |
Figure 7‑19: Total Detachable Coil Market, Global, 2019 – 2029 |
Figure 7‑20: Units Sold by Region, Detachable Coil Market, Global, 2019 – 2029 |
Figure 7‑21: Average Selling Price by Region, Detachable Coil Market, Global, 2019 – 2029 (US$) |
Figure 7‑22: Market Value by Region, Detachable Coil Market, Global, 2019 – 2029 (US$M) |
Figure 7‑23: Bare Platinum Detachable Coil Market, Global, 2019 – 2029 |
Figure 7‑24: Units Sold by Region, Bare Platinum Detachable Coil Market, Global, 2019 – 2029 |
Figure 7‑25: Average Selling Price by Region, Bare Platinum Detachable Coil Market, Global, 2019 – 2029 (US$) |
Figure 7‑26: Market Value by Region, Bare Platinum Detachable Coil Market, Global, 2019 – 2029 (US$M) |
Figure 7‑27: Coated Detachable Coil Market, Global, 2019 – 2029 |
Figure 7‑28: Units Sold by Region, Coated Detachable Coil Market, Global, 2019 – 2029 |
Figure 7‑29: Average Selling Price by Region, Coated Detachable Coil Market, Global, 2019 – 2029 (US$) |
Figure 7‑30: Market Value by Region, Coated Detachable Coil Market, Global, 2019 – 2029 (US$M) |
Figure 7‑31: Leading Competitors, Detachable Coil Market, Global, 2022 |
Figure 8‑1: Liquid Embolic Regions Covered, Global (1 of 2) |
Figure 8‑2: Liquid Embolic Regions Covered, Global (2 of 2) |
Figure 8‑3: Total Liquid Embolic Procedures, Global, 2019 – 2029 |
Figure 8‑4: Liquid Embolic Procedures by Region, Global, 2019 – 2029 |
Figure 8‑5: Liquid Embolic Procedures by Country, North America, 2019 – 2029 |
Figure 8‑6: Liquid Embolic Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
Figure 8‑7: Liquid Embolic Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
Figure 8‑8: Liquid Embolic Procedures by Country, Western Europe, 2019 – 2029 |
Figure 8‑9: Liquid Embolic Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
Figure 8‑10: Liquid Embolic Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
Figure 8‑11: Liquid Embolic Procedures by Country, Middle East, 2019 – 2029 |
Figure 8‑12: Liquid Embolic Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
Figure 8‑13: Liquid Embolic Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
Figure 8‑14: Liquid Embolic Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
Figure 8‑15: Liquid Embolic Procedures by Country, Africa, 2019 – 2029 |
Figure 8‑16: Liquid Embolic Market, Global, 2019 – 2029 |
Figure 8‑17: Units Sold by Region, Liquid Embolic Market, Global, 2019 – 2029 |
Figure 8‑18: Average Selling Price by Region, Liquid Embolic Market, Global, 2019 – 2029 (US$) |
Figure 8‑19: Market Value by Region, Liquid Embolic Market, Global, 2019 – 2029 (US$M) |
Figure 8‑20: Leading Competitors, Liquid Embolic Market, Global, 2022 |
Figure 9‑1: Neurovascular Guidewire Regions Covered, Global (1 of 2) |
Figure 9‑2: Neurovascular Guidewire Regions Covered, Global (2 of 2) |
Figure 9‑3: Neurovascular Guidewire Market, Global, 2019 – 2029 |
Figure 9‑4: Units Sold by Region, Neurovascular Guidewire Market, Global, 2019 – 2029 |
Figure 9‑5: Average Selling Price by Region, Neurovascular Guidewire Market, Global, 2019 – 2029 (US$) |
Figure 9‑6: Market Value by Region, Neurovascular Guidewire Market, Global, 2019 – 2029 (US$M) |
Figure 9‑7: Leading Competitors, Neurovascular Guidewire Market, Global, 2022 |
Figure 10‑1: Neurovascular Catheter Regions Covered, Global (1 of 2) |
Figure 10‑2: Neurovascular Catheter Regions Covered, Global (2 of 2) |
Figure 10‑3: Neurovascular Catheter Market by Segment, Global, 2019 – 2029 (US$M) |
Figure 10‑4: Neurovascular Catheter Market by Region, Global, 2019 – 2029 (US$M) |
Figure 10‑5: Neurovascular Catheter Market, Global, 2019 – 2029 |
Figure 10‑6: Units Sold by Region, Neurovascular Catheter Market, Global, 2019 – 2029 |
Figure 10‑7: Average Selling Price by Region, Neurovascular Catheter Market, Global, 2019 – 2029 (US$) |
Figure 10‑8: Market Value by Region, Neurovascular Catheter Market, Global, 2019 – 2029 (US$M) |
Figure 10‑9: Over-the-Wire Microcatheter Market, Global, 2019 – 2029 |
Figure 10‑10: Units Sold by Region, Over-the-Wire Microcatheter Market, Global, 2019 – 2029 |
Figure 10‑11: Average Selling Price by Region, Over-the-Wire Microcatheter Market, Global, 2019 – 2029 (US$) |
Figure 10‑12: Market Value by Region, Over-the-Wire Microcatheter Market, Global, 2019 – 2029 (US$M) |
Figure 10‑13: Flow-Directed Microcatheter Market, Global, 2019 – 2029 |
Figure 10‑14: Units Sold by Region, Flow-Directed Microcatheter Market, Global, 2019 – 2029 |
Figure 10‑15: Average Selling Price by Region, Flow-Directed Microcatheter Market, Global, 2019 – 2029 (US$) |
Figure 10‑16: Market Value by Region, Flow-Directed Microcatheter Market, Global, 2019 – 2029 (US$M) |
Figure 10‑17: Neurovascular Guiding Catheter Market, Global, 2019 – 2029 |
Figure 10‑18: Units Sold by Region, Neurovascular Guiding Catheter Market, Global, 2019 – 2029 |
Figure 10‑19: Average Selling Price by Region, Neurovascular Guiding Catheter Market, Global, 2019 – 2029 (US$) |
Figure 10‑20: Market Value by Region, Neurovascular Guiding Catheter Market, Global, 2019 – 2029 (US$M) |
Figure 10‑21: Leading Competitors, Neurovascular Catheter Market, Global, 2022 |
Figure 11‑1: Neurovascular Stent Markets Covered |
Figure 11‑2: Neurovascular Stent Regions Covered, Global (1 of 2) |
Figure 11‑3: Neurovascular Stent Regions Covered, Global (2 of 2) |
Figure 11‑4: Neurovascular Stent Procedures by Region, Global, 2019 – 2029 |
Figure 11‑5: Neurovascular Stent Procedures by Country, North America, 2019 – 2029 |
Figure 11‑6: Neurovascular Stent Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
Figure 11‑7: Neurovascular Stent Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
Figure 11‑8: Neurovascular Stent Procedures by Country, Western Europe, 2019 – 2029 |
Figure 11‑9: Neurovascular Stent Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
Figure 11‑10: Neurovascular Stent Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
Figure 11‑11: Neurovascular Stent Procedures by Country, Middle East, 2019 – 2029 |
Figure 11‑12: Neurovascular Stent Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
Figure 11‑13: Neurovascular Stent Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
Figure 11‑14: Neurovascular Stent Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
Figure 11‑15: Neurovascular Stent Procedures by Country, Africa, 2019 – 2029 |
Figure 11‑16: Neurovascular Stent Market by Segment, Global, 2019 – 2029 (US$M) |
Figure 11‑17: Neurovascular Stent Market by Region, Global, 2019 – 2029 (US$M) |
Figure 11‑18: Neurovascular Stent Market, Global, 2019 – 2029 |
Figure 11‑19: Units Sold by Region, Neurovascular Stent Market, Global, 2019 – 2029 |
Figure 11‑20: Average Selling Price by Region, Neurovascular Stent Market, Global, 2019 – 2029 (US$) |
Figure 11‑21: Market Value by Region, Neurovascular Stent Market, Global, 2019 – 2029 (US$M) |
Figure 11‑22: Traditional Neurovascular Stent Market, Global, 2019 – 2029 |
Figure 11‑23: Units Sold by Region, Traditional Neurovascular Stent Market, Global, 2019 – 2029 |
Figure 11‑24: Average Selling Price by Region, Traditional Neurovascular Stent Market, Global, 2019 – 2029 (US$) |
Figure 11‑25: Market Value by Region, Traditional Neurovascular Stent Market, Global, 2019 – 2029 (US$M) |
Figure 11‑26: Flow Diversion Stent Market, Global, 2019 – 2029 |
Figure 11‑27: Units Sold by Region, Flow Diversion Stent Market, Global, 2019 – 2029 |
Figure 11‑28: Average Selling Price by Region, Flow Diversion Stent Market, Global, 2019 – 2029 (US$) |
Figure 11‑29: Market Value by Region, Flow Diversion Stent Market, Global, 2019 – 2029 (US$M) |
Figure 11‑30: Intrasaccular Stent Market, Global, 2019 – 2029 |
Figure 11‑31: Units Sold by Region, Intrasaccular Stent Market, Global, 2019 – 2029 |
Figure 11‑32: Average Selling Price by Region, Intrasaccular Stent Market, Global, 2019 – 2029 (US$) |
Figure 11‑33: Market Value by Region, Intrasaccular Stent Market, Global, 2019 – 2029 (US$M) |
Figure 11‑34: Leading Competitors, Neurovascular Stent Market, Global, 2022 |
Figure 12‑1: Aneurysm Clip Markets Covered |
Figure 12‑2: Aneurysm Clip Regions Covered, Global (1 of 2) |
Figure 12‑3: Aneurysm Clip Regions Covered, Global (2 of 2) |
Figure 12‑4: Total Aneurysm Treatment Procedures by Region, Global, 2019 – 2029 |
Figure 12‑5: Total Aneurysm Treatment Procedures by Country, North America, 2019 – 2029 |
Figure 12‑6: Total Aneurysm Treatment Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
Figure 12‑7: Total Aneurysm Treatment Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
Figure 12‑8: Total Aneurysm Treatment Procedures by Country, Western Europe, 2019 – 2029 |
Figure 12‑9: Total Aneurysm Treatment Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
Figure 12‑10: Total Aneurysm Treatment Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
Figure 12‑11: Total Aneurysm Treatment Procedures by Country, Middle East, 2019 – 2029 |
Figure 12‑12: Total Aneurysm Treatment Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
Figure 12‑13: Total Aneurysm Treatment Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
Figure 12‑14: Total Aneurysm Treatment Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
Figure 12‑15: Total Aneurysm Treatment Procedures by Country, Africa, 2019 – 2029 |
Figure 12‑16: Aneurysm Clip Market by Segment, Global, 2019 – 2029 (US$M) |
Figure 12‑17: Aneurysm Clip Market by Region, Global, 2019 – 2029 (US$M) |
Figure 12‑18: Aneurysm Clip Market, Global, 2019 – 2029 |
Figure 12‑19: Units Sold by Region, Aneurysm Clip Market, Global, 2019 – 2029 |
Figure 12‑20: Average Selling Price by Region, Aneurysm Clip Market, Global, 2019 – 2029 (US$) |
Figure 12‑21: Market Value by Region, Aneurysm Clip Market, Global, 2019 – 2029 (US$M) |
Figure 12‑22: Titanium Aneurysm Clip Market, Global, 2019 – 2029 |
Figure 12‑23: Units Sold by Region, Titanium Aneurysm Clip Market, Global, 2019 – 2029 |
Figure 12‑24: Average Selling Price by Region, Titanium Aneurysm Clip Market, Global, 2019 – 2029 (US$) |
Figure 12‑25: Market Value by Region, Titanium Aneurysm Clip Market, Global, 2019 – 2029 (US$M) |
Figure 12‑26: Cobalt Chromium Aneurysm Clip Market, Global, 2019 – 2029 |
Figure 12‑27: Units Sold by Region, Cobalt Chromium Aneurysm Clip Market, Global, 2019 – 2029 |
Figure 12‑28: Average Selling Price by Region, Cobalt Chromium Aneurysm Clip Market, Global, 2019 – 2029 (US$) |
Figure 12‑29: Market Value by Region, Cobalt Chromium Aneurysm Clip Market, Global, 2019 – 2029 (US$M) |
Figure 12‑30: Leading Competitors, Aneurysm Clip Market, Global, 2022 |
Figure 13‑1: Neurovascular Thrombus Management Markets Covered |
Figure 13‑2: Neurovascular Thrombus Management Regions Covered, Global (1 of 2) |
Figure 13‑3: Neurovascular Thrombus Management Regions Covered, Global (2 of 2) |
Figure 13‑4: Neurovascular Thrombus Management Procedures by Segment, Global, 2019 – 2029 |
Figure 13‑5: Neurovascular Thrombus Management Procedures by Region, Global, 2019 – 2029 |
Figure 13‑6: Neurovascular Thrombus Management Procedures by Country, North America, 2019 – 2029 |
Figure 13‑7: Neurovascular Thrombus Management Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
Figure 13‑8: Neurovascular Thrombus Management Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
Figure 13‑9: Neurovascular Thrombus Management Procedures by Country, Western Europe, 2019 – 2029 |
Figure 13‑10: Neurovascular Thrombus Management Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
Figure 13‑11: Neurovascular Thrombus Management Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
Figure 13‑12: Neurovascular Thrombus Management Procedures by Country, Middle East, 2019 – 2029 |
Figure 13‑13: Neurovascular Thrombus Management Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
Figure 13‑14: Neurovascular Thrombus Management Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
Figure 13‑15: Neurovascular Thrombus Management Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
Figure 13‑16: Neurovascular Thrombus Management Procedures by Country, Africa, 2019 – 2029 |
Figure 13‑17: Neurovascular Thrombus Management Market by Segment, Global, 2019 – 2029 (US$M) |
Figure 13‑18: Neurovascular Thrombus Management Market by Region, Global, 2019 – 2029 (US$M) |
Figure 13‑19: Neurovascular Thrombus Management Market, Global, 2019 – 2029 |
Figure 13‑20: Units Sold by Region, Neurovascular Thrombus Management Market, Global, 2019 – 2029 |
Figure 13‑21: Average Selling Price by Region, Neurovascular Thrombus Management Market, Global, 2019 – 2029 (US$) |
Figure 13‑22: Market Value by Region, Neurovascular Thrombus Management Market, Global, 2019 – 2029 (US$M) |
Figure 13‑23: Stent Retriever Market, Global, 2019 – 2029 |
Figure 13‑24: Units Sold by Region, Stent Retriever Market, Global, 2019 – 2029 |
Figure 13‑25: Average Selling Price by Region, Stent Retriever Market, Global, 2019 – 2029 (US$) |
Figure 13‑26: Market Value by Region, Stent Retriever Market, Global, 2019 – 2029 (US$M) |
Figure 13‑27: Aspiration Catheter Market, Global, 2019 – 2029 |
Figure 13‑28: Units Sold by Region, Aspiration Catheter Market, Global, 2019 – 2029 |
Figure 13‑29: Average Selling Price by Region, Aspiration Catheter Market, Global, 2019 – 2029 (US$) |
Figure 13‑30: Market Value by Region, Aspiration Catheter Market, Global, 2019 – 2029 (US$M) |
Figure 13‑31: Leading Competitors, Neurovascular Thrombus Management Market, Global, 2022 |
Figure 14‑1: Neuromodulation Device Markets Covered |
Figure 14‑2: Neuromodulation Device Regions Covered, Global (1 of 2) |
Figure 14‑3: Neuromodulation Device Regions Covered, Global (2 of 2) |
Figure 14‑4: Total Neuromodulation Procedures by Region, Global, 2019 – 2029 |
Figure 14‑5: Total Neuromodulation Procedures by Country, North America, 2019 – 2029 |
Figure 14‑6: Total Neuromodulation Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
Figure 14‑7: Total Neuromodulation Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
Figure 14‑8: Total Neuromodulation Procedures by Country, Western Europe, 2019 – 2029 |
Figure 14‑9: Total Neuromodulation Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
Figure 14‑10: Total Neuromodulation Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
Figure 14‑11: Total Neuromodulation Procedures by Country, Middle East, 2019 – 2029 |
Figure 14‑12: Total Neuromodulation Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
Figure 14‑13: Total Neuromodulation Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
Figure 14‑14: Total Neuromodulation Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
Figure 14‑15: Total Neuromodulation Procedures by Country, Africa, 2019 – 2029 |
Figure 14‑16: Spinal Cord Stimulation Procedures by Region, Global, 2019 – 2029 |
Figure 14‑17: Spinal Cord Stimulation Procedures by Country, North America, 2019 – 2029 |
Figure 14‑18: Spinal Cord Stimulation Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
Figure 14‑19: Spinal Cord Stimulation Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
Figure 14‑20: Spinal Cord Stimulation Procedures by Country, Western Europe, 2019 – 2029 |
Figure 14‑21: Spinal Cord Stimulation Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
Figure 14‑22: Spinal Cord Stimulation Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
Figure 14‑23: Spinal Cord Stimulation Procedures by Country, Middle East, 2019 – 2029 |
Figure 14‑24: Spinal Cord Stimulation Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
Figure 14‑25: Spinal Cord Stimulation Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
Figure 14‑26: Spinal Cord Stimulation Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
Figure 14‑27: Spinal Cord Stimulation Procedures by Country, Africa, 2019 – 2029 |
Figure 14‑28: Deep Brain Stimulation Procedures by Region, Global, 2019 – 2029 |
Figure 14‑29: Deep Brain Stimulation Procedures by Country, North America, 2019 – 2029 |
Figure 14‑30: Deep Brain Stimulation Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
Figure 14‑31: Deep Brain Stimulation Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
Figure 14‑32: Deep Brain Stimulation Procedures by Country, Western Europe, 2019 – 2029 |
Figure 14‑33: Deep Brain Stimulation Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
Figure 14‑34: Deep Brain Stimulation Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
Figure 14‑35: Deep Brain Stimulation Procedures by Country, Middle East, 2019 – 2029 |
Figure 14‑36: Deep Brain Stimulation Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
Figure 14‑37: Deep Brain Stimulation Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
Figure 14‑38: Deep Brain Stimulation Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
Figure 14‑39: Deep Brain Stimulation Procedures by Country, Africa, 2019 – 2029 |
Figure 14‑40: Sacral Nerve Stimulation Procedures by Region, Global, 2019 – 2029 |
Figure 14‑41: Sacral Nerve Stimulation Procedures by Country, North America, 2019 – 2029 |
Figure 14‑42: Sacral Nerve Stimulation Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
Figure 14‑43: Sacral Nerve Stimulation Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
Figure 14‑44: Sacral Nerve Stimulation Procedures by Country, Western Europe, 2019 – 2029 |
Figure 14‑45: Sacral Nerve Stimulation Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
Figure 14‑46: Sacral Nerve Stimulation Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
Figure 14‑47: Sacral Nerve Stimulation Procedures by Country, Middle East, 2019 – 2029 |
Figure 14‑48: Sacral Nerve Stimulation Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
Figure 14‑49: Sacral Nerve Stimulation Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
Figure 14‑50: Sacral Nerve Stimulation Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
Figure 14‑51: Sacral Nerve Stimulation Procedures by Country, Africa, 2019 – 2029 |
Figure 14‑52: Vagus Nerve Stimulation Procedures by Region, Global, 2019 – 2029 |
Figure 14‑53: Vagus Nerve Stimulation Procedures by Country, North America, 2019 – 2029 |
Figure 14‑54: Vagus Nerve Stimulation Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
Figure 14‑55: Vagus Nerve Stimulation Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
Figure 14‑56: Vagus Nerve Stimulation Procedures by Country, Western Europe, 2019 – 2029 |
Figure 14‑57: Vagus Nerve Stimulation Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
Figure 14‑58: Vagus Nerve Stimulation Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
Figure 14‑59: Vagus Nerve Stimulation Procedures by Country, Middle East, 2019 – 2029 |
Figure 14‑60: Vagus Nerve Stimulation Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
Figure 14‑61: Vagus Nerve Stimulation Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
Figure 14‑62: Vagus Nerve Stimulation Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
Figure 14‑63: Vagus Nerve Stimulation Procedures by Country, Africa, 2019 – 2029 |
Figure 14‑64: Gastric Electric Stimulation Procedures by Region, Global, 2019 – 2029 |
Figure 14‑65: Neuromodulation Device Market by Segment, Global, 2019 – 2029 (US$M) |
Figure 14‑66: Neuromodulation Device Market by Region, Global, 2019 – 2029 (US$M) |
Figure 14‑67: Neuromodulation Device Market, Global, 2019 – 2029 |
Figure 14‑68: Units Sold by Region, Neuromodulation Device Market, Global, 2019 – 2029 |
Figure 14‑69: Average Selling Price by Region, Neuromodulation Device Market, Global, 2019 – 2029 (US$) |
Figure 14‑70: Market Value by Region, Neuromodulation Device Market, Global, 2019 – 2029 (US$M) |
Figure 14‑71: Spinal Cord Stimulation Market, Global, 2019 – 2029 |
Figure 14‑72: Units Sold by Region, Spinal Cord Stimulation Market, Global, 2019 – 2029 |
Figure 14‑73: Average Selling Price by Region, Spinal Cord Stimulation Market, Global, 2019 – 2029 (US$) |
Figure 14‑74: Market Value by Region, Spinal Cord Stimulation Market, Global, 2019 – 2029 (US$M) |
Figure 14‑75: Deep Brain Stimulation Market, Global, 2019 – 2029 |
Figure 14‑76: Units Sold by Region, Deep Brain Stimulation Market, Global, 2019 – 2029 |
Figure 14‑77: Average Selling Price by Region, Deep Brain Stimulation Market, Global, 2019 – 2029 (US$) |
Figure 14‑78: Market Value by Region, Deep Brain Stimulation Market, Global, 2019 – 2029 (US$M) |
Figure 14‑79: Sacral Nerve Stimulation Market, Global, 2019 – 2029 |
Figure 14‑80: Units Sold by Region, Sacral Nerve Stimulation Market, Global, 2019 – 2029 |
Figure 14‑81: Average Selling Price by Region, Sacral Nerve Stimulation Market, Global, 2019 – 2029 (US$) |
Figure 14‑82: Market Value by Region, Sacral Nerve Stimulation Market, Global, 2019 – 2029 (US$M) |
Figure 14‑83: Vagus Nerve Stimulation Market, Global, 2019 – 2029 |
Figure 14‑84: Units Sold by Region, Vagus Nerve Stimulation Market, Global, 2019 – 2029 |
Figure 14‑85: Average Selling Price by Region, Vagus Nerve Stimulation Market, Global, 2019 – 2029 (US$) |
Figure 14‑86: Market Value by Region, Vagus Nerve Stimulation Market, Global, 2019 – 2029 (US$M) |
Figure 14‑87: Gastric Electric Stimulation Market, Global, 2019 – 2029 |
Figure 14‑88: Units Sold by Region, Gastric Electric Stimulation Market, Global, 2019 – 2029 |
Figure 14‑89: Average Selling Price by Region, Gastric Electric Stimulation Market, Global, 2019 – 2029 (US$) |
Figure 14‑90: Market Value by Region, Gastric Electric Stimulation Market, Global, 2019 – 2029 (US$M) |
Figure 14‑91: Leading Competitors, Neuromodulation Device Market, Global, 2022 |
Figure 15‑1: Intrathecal Pump Regions Covered, Global (1 of 2) |
Figure 15‑2: Intrathecal Pump Regions Covered, Global (2 of 2) |
Figure 15‑3: Total Intrathecal Pump Procedures, Global, 2019 – 2029 |
Figure 15‑4: Intrathecal Pump Procedures by Region, Global, 2019 – 2029 |
Figure 15‑5: Intrathecal Pump Procedures by Country, North America, 2019 – 2029 |
Figure 15‑6: Intrathecal Pump Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
Figure 15‑7: Intrathecal Pump Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
Figure 15‑8: Intrathecal Pump Procedures by Country, Western Europe, 2019 – 2029 |
Figure 15‑9: Intrathecal Pump Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
Figure 15‑10: Intrathecal Pump Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
Figure 15‑11: Intrathecal Pump Procedures by Country, Middle East, 2019 – 2029 |
Figure 15‑12: Intrathecal Pump Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
Figure 15‑13: Intrathecal Pump Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
Figure 15‑14: Intrathecal Pump Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
Figure 15‑15: Intrathecal Pump Procedures by Country, Africa, 2019 – 2029 |
Figure 15‑16: Intrathecal Pump Market, Global, 2019 – 2029 |
Figure 15‑17: Units Sold by Region, Intrathecal Pump Market, Global, 2019 – 2029 |
Figure 15‑18: Average Selling Price by Region, Intrathecal Pump Market, Global, 2019 – 2029 (US$) |
Figure 15‑19: Market Value by Region, Intrathecal Pump Market, Global, 2019 – 2029 (US$M) |
Figure 15‑20: Leading Competitors, Intrathecal Pump Market, Global, 2022 |
Figure 16‑1: Stereotactic Regions Covered, Global (1 of 2) |
Figure 16‑2: Stereotactic Regions Covered, Global (2 of 2) |
Figure 16‑3: Stereotactic Market, Global, 2019 – 2029 |
Figure 16‑4: Units Sold by Region, Stereotactic Market, Global, 2019 – 2029 |
Figure 16‑5: Average Selling Price by Region, Stereotactic Market, Global, 2019 – 2029 (US$) |
Figure 16‑6: Market Value by Region, Stereotactic Market, Global, 2019 – 2029 (US$M) |
Figure 16‑7: Leading Competitors, Stereotactic Market, Global, 2022 |